Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma
ContributorsDutoit Vallotton, Valérie; Migliorini, Denis; Ranzanici, Giulia Gabriella; Marinari, Eliana; Widmer-Schnuriger, Valérie; Lobrinus, Johannes Alexander; Momjian, Shahan Marc; Costello, Joseph; Walker, Paul Richard ; Okada, Hideho; Weinschenk, Toni; Herold-Mende, Christel; Dietrich, Pierre-Yves
Published inOncoImmunology, vol. 7, no. 2, e1391972
Publication date2018
Abstract
Citation (ISO format)
DUTOIT VALLOTTON, Valérie et al. Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. In: OncoImmunology, 2018, vol. 7, n° 2, p. e1391972. doi: 10.1080/2162402X.2017.1391972
Main files (1)
Article (Published version)
Identifiers
- PID : unige:104860
- DOI : 10.1080/2162402X.2017.1391972
- PMID : 29308320
ISSN of the journal2162-4011